Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
المؤلفون المشاركون
Feldman, Mark
Mada, Pradeep Kumar
Castano, Gabriel
Malus, Matthew E.
Parvathaneni, Arvin
Chen, Bing
Adley, Sharon
Moore, Maureen
Hieda, Michinari
Alam, Mohammed J.
King, John William
المصدر
International Journal of Hepatology
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-6، 6ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-01-13
دولة النشر
مصر
عدد الصفحات
6
التخصصات الرئيسية
الملخص EN
Aim.
To assess the effect of treating chronic hepatitis C virus (HCV) infection with direct acting antiviral drugs (DAAs) on glycemic control in patients with concomitant diabetes mellitus (DM).
Methods.
We performed a retrospective case-control study in a viral hepatitis ambulatory clinic in Shreveport, Louisiana, during the period 11/01/2014 to 12/31/2017.
All the clinic patient ages 18 years and above with treatment-naïve/biopsy-proven chronic hepatitis C and DM (hemoglobin A1C level≥6.5%) who were eligible for treatment were included in the study.
Of 118 such patients, 59 were treated with oral DAAs for 8-12 weeks with the goal of achieving a sustained virologic response (SVR).
A control group of 59 patients did not receive treatment for their hepatitis C and was followed in the clinic.
Patients in the control group did not receive treatment either due to insurance issues or refusal of hepatitis C treatment.
Results.
Fifty-five of the 59 patients treated with DAAs (93%) achieved a SVR.
Six months after treatment completion, their mean±SEM HbA1C level had decreased by 1.1±0.03% (P<0.0001).
Four of the 59 patients treated with DAAs did not achieve a SVR.
Their mean HbA1C 6 months after treatment completion had increased by 0.8±0.2%.
Furthermore, there was no improvement in HbA1C levels over time in the untreated group (mean HbA1C increase, 0.2±0.05%; P<0.0001 vs.
the treatment group, which had a mean HbA1C decrease of 0.9±0.2%).
Conclusion.
This controlled study demonstrated that treatment of chronic hepatitis C with DAAs results in statistically significant and meaningful reductions in hemoglobin A1C levels in patients with coexisting diabetic mellitus if a SVR is achieved.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Mada, Pradeep Kumar& Malus, Matthew E.& Parvathaneni, Arvin& Chen, Bing& Castano, Gabriel& Adley, Sharon…[et al.]. 2020. Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus. International Journal of Hepatology،Vol. 2020, no. 2020, pp.1-6.
https://search.emarefa.net/detail/BIM-1171456
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Mada, Pradeep Kumar…[et al.]. Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus. International Journal of Hepatology No. 2020 (2020), pp.1-6.
https://search.emarefa.net/detail/BIM-1171456
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Mada, Pradeep Kumar& Malus, Matthew E.& Parvathaneni, Arvin& Chen, Bing& Castano, Gabriel& Adley, Sharon…[et al.]. Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus. International Journal of Hepatology. 2020. Vol. 2020, no. 2020, pp.1-6.
https://search.emarefa.net/detail/BIM-1171456
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1171456
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر